South Africa’s Competition Commission (CompCom) has initiated separate investigations against three global pharmaceutical companies over concerns of excessive pricing of cancer medicines.
CompCom called its investigation into Roche, Pfizer and Aspen “a matter of grave national concern”.
☛ Want to stay up to date with the news? Sign up to our daily bulletin.